CXCL8 and diabetes mellitus: Inhibited cyclooxygenase-2 (COX-2) and its product prostaglandin E (PGE), reduce the synthesis of IL-8, reduce intestinal inflammationEnhanced glucose transportation or inhibit gluconeogenesis.Inhibited the formation of ACE, alleviate diabetes complications.